NCT06268951Enrolling by invitation
Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis
Mayo ClinicClinicalTrials.gov
Study focus
- Disease/Condition
- Endometriosis
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Mayo Clinic
- Location
- Rochester, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Feb 01, 2024
- End date
- Dec 01, 2027
- Enrollment
- 50 participants
Primary outcome
Symptom severity due to abdominal wall endometriosis following ablation.
Summary
To determine the characteristics of recovery and symptom relief following ablation of
 abdominal wall endometriosis.
ICD-10 classifications
EndometriosisOther endometriosisEndometriosis, unspecifiedEndometriosis of uterusEndometriosis of ovary
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06268951
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06268951 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Enrolling by invitation. The study focuses on Endometriosis. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.